Review: 'Through the Shadowlands’ describes Julie Rehmeyer's ME/CFS Odyssey
I should note at the outset that this review is based on an audio version of the galleys and the epilogue from the finished work. Julie Rehmeyer sent me the final version as a PDF, but for some reason my text to voice software (Kurzweil) had issues with it. I understand that it is...
Discuss the article on the Forums.

Pfizer Moves May Dim Prospect for New Antibiotics

Discussion in 'Other Health News and Research' started by leelaplay, Feb 6, 2011.

  1. leelaplay

    leelaplay member

    Messages:
    1,546
    Likes:
    147
    http://www.medpagetoday.com/Infecti...ailyHeadlines&utm_source=mSpoke&userid=242714

    "The plan will not sit well with the infectious disease community, said Brad Spellberg, MD, of the University of California Los Angeles, and a member of IDSA's Antimicrobial Availability Task Force.

    "It's just a crushing blow," he told MedPage Today in a phone interview. He said Pfizer had been one of a handful of big companies in the antibiotic field and that the decision would have a crippling effect on antibiotic development."
     

See more popular forum discussions.

Share This Page